Usefulness of transanal endoscopic surgery for carcinoid tumor in the upper and middle rectum
- PMID: 16021383
- DOI: 10.1007/s00464-004-2076-8
Usefulness of transanal endoscopic surgery for carcinoid tumor in the upper and middle rectum
Abstract
Background: This study evaluated the indications and outcome for transanal endoscopic surgery (TES) used to manage rectal carcinoid tumor as compared with those of conventional transanal local resection (TAR).
Methods: The retrospective study subjects were 28 patients with rectal carcinoid tumor treated by TES (n = 17) or TAR (n = 11) between January 1995 and December 2001. Patient and tumor characteristics, operative results, and postoperative outcomes were compared between the two groups.
Results: The distance from the anal verge to the distal tumor margin in the TES group (range, 4-12 cm; median, 6.8 cm) was significantly greater than in the TAR group (range, 3-6 cm; median, 4.5 cm) (p = 0.001). The median tumor diameter was 5.5 mm (range, 3-11 mm) in the TES group and 5.0 mm (range, 3-8 mm) in the TAR group, showing no statistical difference. Microscopically, resected specimens in both groups were typical carcinoid tumors restricted to the submucosal layer. No recurrence was noted in either group.
Conclusion: Whereas TES is useful for patients with small rectal carcinoid tumor of typical histology within the submucosal layer in the upper and middle rectum, TAR is effective for accessing the lower rectum.
Similar articles
-
Transanal endoscopic microsurgery in the treatment of rectal carcinoid tumor.Surg Endosc. 2007 Jun;21(6):970-4. doi: 10.1007/s00464-006-9155-y. Epub 2007 Feb 7. Surg Endosc. 2007. PMID: 17285371
-
Endoscopic submucosal dissection for treatment of rectal carcinoid tumors.Gastrointest Endosc. 2010 Jul;72(1):143-9. doi: 10.1016/j.gie.2010.01.040. Epub 2010 Apr 9. Gastrointest Endosc. 2010. PMID: 20381798
-
Treatment outcomes of endoscopic resection for rectal carcinoid tumors: an analysis of the resectability and long-term results from 46 consecutive cases.Scand J Gastroenterol. 2016 Dec;51(12):1489-1494. doi: 10.1080/00365521.2016.1216591. Epub 2016 Aug 9. Scand J Gastroenterol. 2016. PMID: 27687741
-
Minimally invasive surgery for carcinoid tumors in the rectum.Biomed Pharmacother. 2002;56 Suppl 1:222s-226s. doi: 10.1016/s0753-3322(02)00218-4. Biomed Pharmacother. 2002. PMID: 12487287 Review.
-
[Transanal endoscopic microsurgery for tumours in rectum].Tidsskr Nor Laegeforen. 2007 Nov 15;127(22):2954-8. Tidsskr Nor Laegeforen. 2007. PMID: 18026244 Review. Norwegian.
Cited by
-
Initial application of transanal endoscopic microsurgery for high-risk lower rectal gastrointestinal stromal tumor after imatinib mesylate neoadjuvant chemotherapy: A case report.Medicine (Baltimore). 2017 Jul;96(29):e7538. doi: 10.1097/MD.0000000000007538. Medicine (Baltimore). 2017. PMID: 28723770 Free PMC article.
-
Clinicopathological characteristics of rectal carcinoids.Int J Colorectal Dis. 2010 Sep;25(9):1087-92. doi: 10.1007/s00384-010-0949-y. Epub 2010 Apr 16. Int J Colorectal Dis. 2010. PMID: 20397020
-
Transanal Minimally Invasive Surgery (TAMIS): a clinical spotlight review.Surg Endosc. 2017 Oct;31(10):3791-3800. doi: 10.1007/s00464-017-5636-4. Epub 2017 Jun 27. Surg Endosc. 2017. PMID: 28656337 No abstract available.
-
Transanal endoscopic microsurgery in the treatment of rectal neuroendocrine tumors: a retrospective 10-year single-center experience.Langenbecks Arch Surg. 2025 Apr 22;410(1):137. doi: 10.1007/s00423-025-03704-w. Langenbecks Arch Surg. 2025. PMID: 40261413 Free PMC article.
-
Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors.World J Gastroenterol. 2015 Aug 14;21(30):9142-9. doi: 10.3748/wjg.v21.i30.9142. World J Gastroenterol. 2015. PMID: 26290641 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical